PharmaCyte Biotech Updates Shareholders on ASCO Presentation to Oncologists

PharmaCyte Biotech Updates Shareholders on ASCO Presentation to Oncologists


PharmaCyte Biotech, Inc. , a clinical stage biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-BoxA , today provided an update from the company's meeting with leading clinical oncologists who are interested in participating in PharmaCyte's planned pivotal clinical trial in locally advanced pancreas cancer . The meeting was by invitation only during this year's 53rd annual meeting of the American Society of Clinical Oncology in Chicago.



from Biotech News